Ikarian Capital, LLC Catalyst Biosciences, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.36 - $1.78 $171,585 - $848,392	-476,625 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.51 - $1.0 $11,362 - $22,279	22,279 Added 4.9%	476,625 $314,000
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $479,508 - $657,103	-126,854 Reduced 21.83%	454,346 $1.87 Million
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $2.87 Million - $4.16 Million	581,200 New	581,200 $2.93 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.